Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Top Shorted Stocks by Short Interest: Beyond Meat, SunPower
By Danny Peterson
Mar 19, 2021 2:32 PM EDT
INVESTING
Most Heavily Shorted Stocks by Float Shorted: PubMatic, Gogo
By Danny Peterson
Feb 25, 2021 9:45 PM EST
PRESS RELEASES
Esperion To Report Fourth Quarter And Full Year 2020 Financial Results February 23, 2021
By GlobeNewswire
Feb 9, 2021 8:00 AM EST
PRESS RELEASES
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
By GlobeNewswire
Jan 29, 2021 5:00 PM EST
PRESS RELEASES
ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results And Further Commits To Unmet Patient Needs With Oral PCSK9 Inhibitor Program
By GlobeNewswire
Jan 13, 2021 6:26 AM EST
PRESS RELEASES
First-in-class Cholesterol-lowering Treatment NILEMDO® * (bempedoic Acid) Tablet And Its Combination With Ezetimibe NUSTENDI® * (bempedoic Acid And Ezetimibe) Tablet Approved In Switzerland
By GlobeNewswire
Dec 16, 2020 3:00 AM EST
PRESS RELEASES
Esperion Launches U.S. Direct-to-Consumer Campaign To Accelerate Awareness Of NEXLETOL® (bempedoic Acid) Tablets And Increase Awareness Of Bad Cholesterol
By GlobeNewswire
Sep 28, 2020 4:06 PM EDT
JIM CRAMER
Coronavirus and Your Portfolio: Cramer's 'Mad Money' Recap (Tuesday 2/25/20)
By Scott Rutt
Feb 25, 2020 8:31 PM EST
JIM CRAMER
Tsunami of Innovation: Cramer's 'Mad Money' Recap
By Scott Rutt
Nov 21, 2019 8:59 PM EST
JIM CRAMER
AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round
By Scott Rutt
Nov 21, 2019 8:39 PM EST
STOCKS
15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies
By Kinsey Grant
Mar 20, 2018 2:58 PM EDT
JIM CRAMER
Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round
By Scott Rutt
Oct 17, 2017 9:27 PM EDT
JIM CRAMER
Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap
By Scott Rutt
Oct 17, 2017 9:14 PM EDT
JIM CRAMER
Markets Focus on Business: Cramer's 'Mad Money' Recap
By Scott Rutt
Aug 28, 2017 8:11 PM EDT
HEALTH
Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks
By Armie Margaret Lee
Jul 14, 2017 4:11 PM EDT
HEALTH
Biotech Movers: Akebia Shares Down After Pricing Stock Offering
By Armie Margaret Lee
Jun 29, 2017 9:26 AM EDT
STOCKS
Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct
By Roberto Pedone
Jun 9, 2017 1:19 PM EDT
JIM CRAMER
Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round
By Scott Rutt
Apr 11, 2017 6:20 AM EDT
JIM CRAMER
These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap
By Scott Rutt
Apr 11, 2017 6:11 AM EDT
HEALTH
Biotech Premarket Movers: Esperion, Minerva and BioCryst
By Armie Margaret Lee
Mar 21, 2017 9:32 AM EDT
STOCKS
How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More
By Jonas Elmerraji
Mar 20, 2017 2:03 PM EDT
HEALTH
Biotech Premarket Movers: CytomX, Aevi, Esperion
By Armie Margaret Lee
Mar 20, 2017 9:35 AM EDT
HEALTH
AveXis, Esperion and Amgen Among Biotech Movers
By Armie Margaret Lee
Mar 17, 2017 11:03 AM EDT
JIM CRAMER
PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round
By Scott Rutt
Feb 28, 2017 6:20 AM EST
JIM CRAMER
Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap
By Scott Rutt
Feb 28, 2017 6:15 AM EST